Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
CA 2253636 C · Owner: Plosila, Laura · Inventors: Plosila, Laura; Tucker, Kenneth
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides and antibodies , that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic prophylactic or therapeutic , compositions including vaccines, comprising OMP106 polypeptide and/or OMP106derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 28, 1997 and granted April 22, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 28, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 28, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.